# Eckert & Ziegler forms joint venture with TCL Healthcare for tumor irradiation devices in China

Eckert & Ziegler AG and TCL Healthcare Equipment (Shanghai) Co., Ltd. formed a joint venture, TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd., to develop, produce and distribute advanced tumor irradiation devices in China. The JV is held 49% by EZAG and 51% by TCL.

- Type: Partnership
- Announced: 2019-08-01
- Where: Wuxi, China, China
- Status: announced
- Products: tumor irradiation devices, brachytherapy equipment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [TCL Healthcare Equipment (Shanghai)](https://endata.com/companies/41011.md) (partner)
- [Eckert & Ziegler](https://endata.com/companies/41023.md) (partner)

## Sources

- [eqs-news.com](https://www.eqs-news.com/news/corporate/eckert-ziegler-forms-joint-venture-for-tumor-irradiation-devices-in-china/f5dae54c-504b-45da-94cd-70828e81abbc_en), 2019-08-01: "We look forward to advancing brachytherapy with a strong partner in China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.